Registry of Lobbyists
| Organization: | Psychedelics Canada—The Canada Psychedelic Businesses Association |
| Associated registration: | 952635-372370-1 |
| Communication date: | 2023-06-13 |
| Posted date: | 2023-07-27 |
| Designated Public Office Holders who participated in the communication: |
Daniel Keene,
Associate Director
Office of Clinical Trials, Health Canada (HC) Jennifer Pelley, Director Office of Legislative and Regulatory Affairs, Health Canada (HC) Carol Anne Chénard, Director Office of Controlled Substances, Health Canada (HC) Kathy Soltys, Director Office of Clinical Trials, Health Canada (HC) |
| Subject Matter of the communication: | Health, Justice and Law Enforcement, Science and Technology |
| Responsible Officer who filed this communication report: | Liam Bedard |
| As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |